Lexeo Therapeutics, Correlations
LXEO Stock | 3.99 0.45 10.14% |
The current 90-days correlation between Lexeo Therapeutics, and flyExclusive, is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lexeo Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lexeo Therapeutics, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Lexeo Therapeutics, Correlation With Market
Modest diversification
The correlation between Lexeo Therapeutics, Common and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lexeo Therapeutics, Common and DJI in the same portfolio, assuming nothing else is changed.
Lexeo |
Moving together with Lexeo Stock
0.63 | CDIOW | Cardio Diagnostics | PairCorr |
0.8 | ELVN | Enliven Therapeutics | PairCorr |
0.85 | SCLX | Scilex Holding | PairCorr |
0.86 | ASMB | Assembly Biosciences Downward Rally | PairCorr |
0.86 | CMND | Clearmind Medicine Common | PairCorr |
0.61 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.61 | CAT | Caterpillar | PairCorr |
0.68 | MSFT | Microsoft | PairCorr |
Moving against Lexeo Stock
0.82 | LUCD | Lucid Diagnostics | PairCorr |
0.74 | WM | Waste Management | PairCorr |
0.67 | PG | Procter Gamble | PairCorr |
0.5 | GE | GE Aerospace | PairCorr |
0.35 | PLX | Protalix Biotherapeutics | PairCorr |
0.84 | JNJ | Johnson Johnson | PairCorr |
0.8 | T | ATT Inc Aggressive Push | PairCorr |
0.62 | IBM | International Business | PairCorr |
0.51 | CSCO | Cisco Systems Aggressive Push | PairCorr |
0.51 | INTC | Intel | PairCorr |
0.51 | MMM | 3M Company | PairCorr |
0.46 | DD | Dupont De Nemours | PairCorr |
0.46 | CVX | Chevron Corp | PairCorr |
0.43 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lexeo Stock performing well and Lexeo Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lexeo Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CB | 1.00 | 0.13 | 0.11 | 0.36 | 1.03 | 2.22 | 5.98 | |||
PLMR | 1.80 | 0.44 | 0.24 | 0.36 | 1.45 | 4.38 | 17.65 | |||
CNA | 1.01 | 0.06 | 0.05 | 0.09 | 1.18 | 2.17 | 5.91 | |||
WETO | 2.66 | (0.19) | 0.00 | (0.44) | 0.00 | 4.44 | 10.00 | |||
VRRM | 1.19 | (0.15) | 0.00 | (0.34) | 0.00 | 2.23 | 14.15 | |||
HAFN | 2.21 | (0.31) | 0.00 | 1.84 | 0.00 | 3.96 | 21.41 | |||
FLYX | 4.03 | 0.52 | 0.11 | (0.37) | 4.22 | 9.35 | 25.27 |
Lexeo Therapeutics, Corporate Management
Ryan McHenry | VP Controller | Profile | |
Rand Monaghan | Vice Finance | Profile | |
Paul McCormac | Chief Officer | Profile | |
Jordan MD | Cardiology Science | Profile | |
Jenny Robertson | Chief Officer | Profile |